These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Treatment of germ cell tumors at the threshold of the third millennium]. Géczi L; Biron P; Droz JP Orv Hetil; 2001 Aug; 142(31):1673-9. PubMed ID: 11556261 [TBL] [Abstract][Full Text] [Related]
3. [Germ cell tumors of the testes: state of the art]. Fléchon A; Droz JP Cancer Radiother; 2000; 4(1):27-31. PubMed ID: 10742806 [TBL] [Abstract][Full Text] [Related]
4. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group. Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C; J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987 [TBL] [Abstract][Full Text] [Related]
5. Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial. Hinton S; Catalano PJ; Einhorn LH; Nichols CR; David Crawford E; Vogelzang N; Trump D; Loehrer PJ Cancer; 2003 Apr; 97(8):1869-75. PubMed ID: 12673712 [TBL] [Abstract][Full Text] [Related]
6. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996]. Fléchon A; Biron P; Philip I; Blay JY; Droz JP Bull Cancer; 1999 Apr; 86(4):391-9. PubMed ID: 10341344 [TBL] [Abstract][Full Text] [Related]
7. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors. Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858 [TBL] [Abstract][Full Text] [Related]
8. [The current therapeutic strategy in testicular cancer]. Miron L Rev Med Chir Soc Med Nat Iasi; 1995; 99(3-4):29-39. PubMed ID: 9455346 [TBL] [Abstract][Full Text] [Related]
9. [High-dose chemotherapy with peripheral blood stem cell autotransplantation for patients with poor-risk testicular germ cell tumors--pilot study of the Japan Blood Cell Transplantation Study Group]. Nakagawa S; Miki T; Akaza H; Ozono S; Okano T; Sonoda Y; Tsukamoto T; Terachi T; Naito K; Naito S; Nishiyama T; Nonomura N; Hara I; Hoshi S; Yoshida O Hinyokika Kiyo; 1999 Nov; 45(11):805-9. PubMed ID: 10637748 [TBL] [Abstract][Full Text] [Related]
10. Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors. Motzer RJ; Nichols CJ; Margolin KA; Bacik J; Richardson PG; Vogelzang NJ; Bajorin DF; Lara PN; Einhorn L; Mazumdar M; Bosl GJ J Clin Oncol; 2007 Jan; 25(3):247-56. PubMed ID: 17235042 [TBL] [Abstract][Full Text] [Related]
13. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update]. Schmidt P; Haas RJ; Göbel U; Calaminus G Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897 [TBL] [Abstract][Full Text] [Related]
14. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy. Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521 [TBL] [Abstract][Full Text] [Related]
15. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP. Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP; J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419 [TBL] [Abstract][Full Text] [Related]
16. [Testicular germ cell tumors: prognosis]. Miladi M; Peyromaure M; Remi J; Beuzeboc P; Debre B; Zerbib M Prog Urol; 2003 Feb; 13(1):92-7. PubMed ID: 12703360 [TBL] [Abstract][Full Text] [Related]
17. [Management of non-seminomatous germ cell tumors of the testes]. Kawai K; Akaza H Gan To Kagaku Ryoho; 2000 Apr; 27(4):522-9. PubMed ID: 10790993 [TBL] [Abstract][Full Text] [Related]
18. [Treatment outcome on 52 patients with 53 testicular germ cell tumors]. Yokoyama M; Nemoto K; Kanemura M; Kitahara K; Oda H; Murata H; Matsunaga Y Hinyokika Kiyo; 1998 Nov; 44(11):789-94. PubMed ID: 9893223 [TBL] [Abstract][Full Text] [Related]
19. Incorporation of TIP (paclitaxel, ifosfamide, cisplatin) into first-line therapy for intermediate to poor risk testicular germ cell tumors with unfavorable marker decline after initial two cycles chemotherapy: a report of three cases. Ishioka J; Kageyama Y; Ichiyanagi N; Fukuda H; Higashi Y Int J Urol; 2007 May; 14(5):455-7. PubMed ID: 17511735 [TBL] [Abstract][Full Text] [Related]
20. Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience. Hara I; Miyake H; Yamada Y; Yamanaka K; Furukawa J; Kumano M; Takenaka A; Fujisawa M Anticancer Drugs; 2006 Oct; 17(9):1057-66. PubMed ID: 17001179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]